Lunai Bioworks Inc. (LNAI) Stock
LNAI Key Statistics
About Lunai Bioworks Inc.
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
CEO: David H. Weinstein. Company website
LNAI — Frequently Asked Questions
What is the LNAI stock price today?
Lunai Bioworks Inc. (LNAI) trades at $2.88, up 21.01% on the day, as of Sep 20, 2026 15:01 UTC.
What is Lunai Bioworks Inc.'s market cap?
Lunai Bioworks Inc. has a market capitalisation of $51.26M, calculated from the live LNAI share price and shares outstanding.
What is the P/E ratio of LNAI?
LNAI has no meaningful price-to-earnings ratio: Lunai Bioworks Inc. lost $7.55 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Lunai Bioworks Inc. make?
Lunai Bioworks Inc. generated revenue of $0.00 over the trailing twelve months.
What is the 52-week range for LNAI?
LNAI has traded between $0.15 and $5.02 over the past 52 weeks, and the last price is 42.6% below that high.
Is Lunai Bioworks Inc. profitable?
Yes. Lunai Bioworks Inc. keeps 0.00% of revenue as net income over the trailing twelve months.
What sector is Lunai Bioworks Inc. in?
Lunai Bioworks Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in US .
Who is the CEO of Lunai Bioworks Inc.?
David H. Weinstein is the chief executive of Lunai Bioworks Inc., which employs 29 people.
Where can I track LNAI in real time?
QFI Terminal shows LNAI with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See LNAI live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open LNAI in Terminal See plans